Digestive Disease Interventions 2019; 03(S 01): S1-S15
DOI: 10.1055/s-0039-1689029
Oral Presentations
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA

Stent Migration and Management: Complication of Hepatovascular Interventional Procedures

Michael Chih-Yang Juan
1   Department of Radiology, Section of Interventional Radiology, Cleveland Clinic Foundation, Cleveland, Ohio
,
Zahra Karimloo
1   Department of Radiology, Section of Interventional Radiology, Cleveland Clinic Foundation, Cleveland, Ohio
,
Baljendra Kapoor
1   Department of Radiology, Section of Interventional Radiology, Cleveland Clinic Foundation, Cleveland, Ohio
,
Pilar Bayona
1   Department of Radiology, Section of Interventional Radiology, Cleveland Clinic Foundation, Cleveland, Ohio
› Author Affiliations
Further Information

Publication History

Publication Date:
03 May 2019 (online)

 
 

    Introduction: Stent migration is a relatively uncommon complication during hepatovascular interventions such as transjugular intrahepatic portosystemic shunt placement and hepatic vein recanalization. However, due to the risk of central embolization to critical structures including the inferior vena cava, right atrium, right ventricle, and pulmonary artery, stent migration can result in life-threatening consequences if not managed urgently. This exhibit will discuss technical challenges of stent placement during hepatovascular interventions, complications of stent malpositioning, stent retrieval techniques, and examples of stent migration outcomes.

    Content Organization:

    1. Discuss technical challenges of stent placement during hepatovascular interventional procedures.

    2. Practical solutions for stent misplacement, recoil, and migration.

    3. Different techniques of stent retrieval and repositioning.

    Learning Points: Stent migration is a potentially fatal complication during hepatovascular interventional procedures. Knowledge and technical adeptness to perform a variety of stent retrieval techniques are indispensable in mitigating irreversible adverse events.


    #

    No conflict of interest has been declared by the author(s).